Provision of immunisations which protect against, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib) and hepatitis B programmes (2028).

The UK Health Security Agency (UKHSA) is conducting a pre-market engagement exercise for the UK National Immunisation Programmes. Insights gained will help shape future procurement strategy and advance UKHSA's objectives to respond to health threats, strengthen partnerships, and enhance supply chain resilience. The purpose of this market engagement is to: - Share future procurement proposals: 1. Combine vaccine procurements where possible to achieve improved value for money for the UK taxpayer 2. Enhance supply chain resilience, through potential opportunities for UK manufacturing, creating or expanding upon current capabilities by onshoring elements of the vaccine supply chain. - Understand supplier’s perspective of the opportunities available and challenges which may arise in pursuit of the above proposals. The context of the proposal is a potential joint procurement activity for immunisations which protect against, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib) and hepatitis B programmes. These programmes are being explored together as there are multiple products available with overlapping coverage and use in different age groups. UKHSA welcomes insight from a broad range of vaccine manufacturers, regardless of the direct relevance of their product portfolio to inform our broader planning objectives of combined procurement structures and supply chain resilience through onshoring. If you are interested in participating in this activity, please register your interest via the Atamis eTendering system, access here https://atamis-1928.my.site.com/s/Welcome and select ‘Accepted’. 1:1 meetings with interested suppliers shall be scheduled for Mid August 2026, and UKHSA shall share some questions for discussion ahead of the meeting to enable productive discussions.